Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine-Reference-Cited by-同舟云学术

Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine

Published:2016-02-11 Issue:8 Volume:76 Page:744-756
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Kawahara Takashi¹²³,Aljarah Ali Kadhim¹⁴,Shareef Hasanain Khaleel¹⁵,Inoue Satoshi¹,Ide Hiroki¹,Patterson John D.¹,Kashiwagi Eiji¹,Han Bin¹,Li Yi²,Zheng Yichun¹²,Miyamoto Hiroshi¹²

Affiliation:

1. Departments of Pathology and Urology; Johns Hopkins University School of Medicine; Baltimore Maryland

2. Department of Pathology and Laboratory Medicine; University of Rochester Medical Center; Rochester New York

3. Department of Urology; Yokohama City University Graduate School of Medicine; Yokohama Japan

4. Department of Biology; University of Baghdad College of Science; Baghdad Iraq

5. Department of Biology; University of Babylon College of Science for Women; Babylon Iraq

Publisher

Wiley

Subject

Urology,Oncology

Reference33 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Androgen deprivation therapy for prostate cancer;Singer;Expert Opin Pharmacother,2008

3. Treating patients with metastatic castration-resistant prostate cancer: A comprehensive review of available therapies;Crawford;J Urol,2015

4. Risk factors for metastatic castration-resistant prostate cancer (CRPC) predict long-term treatment with docetaxel;Kawahara;PLoS ONE,2012

5. Androgen receptor antagonists in the treatment of prostate cancer;Kawahara;Clin Immunol Endocr Metab Drugs,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2024-02-17

2. Investigating the crosstalk between chronic stress and immune cells: implications for enhanced cancer therapy;Frontiers in Neuroscience;2023-11-28

3. Functional material-mediated wireless physical stimulation for neuro-modulation and regeneration;Journal of Materials Chemistry B;2023

4. Circ_0022340 promotes colorectal cancer progression via HNRNPC/EBF1/SYT7 or miR-382-5p/ELK1 axis;Cellular and Molecular Biology;2022-07-31

5. ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis;Frontiers in Molecular Biosciences;2021-12-13